136 related articles for article (PubMed ID: 32958220)
1. [Nice-Saint-Paul de Vence 2020 recommendations for clinical practice: Management of metastatic and/or relapsing endometrial cancer].
Alexandre J; Le Frere-Belda MA; Prulhiere K; Treilleux I; Leary A; Pomel C; Chargari C; Ducassou A; Joly F;
Bull Cancer; 2020 Oct; 107(10):1006-1018. PubMed ID: 32958220
[TBL] [Abstract][Full Text] [Related]
2. [Not Available].
Alexandre J; Le Frère-Belda MA; Angelergues A; Ferron G; Treilleux I; Gaillard AL; Frenel JS; You B; Rouleau E; Lortholary A; Ray-Coquard I; Joly F;
Bull Cancer; 2023 Jun; 110(6S):6S34-6S43. PubMed ID: 37573037
[TBL] [Abstract][Full Text] [Related]
3. [Not Available].
Jeanne C; Treilleux I; Le Frère-Belda MA; Alexandre J; Joly F; Rouleau E
Bull Cancer; 2023 Jun; 110(6S):6S10-6S19. PubMed ID: 37573035
[TBL] [Abstract][Full Text] [Related]
4. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
[TBL] [Abstract][Full Text] [Related]
5. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
[TBL] [Abstract][Full Text] [Related]
6. Mismatch Repair Deficiency in Endometrial Cancer: Immunohistochemistry Staining and Clinical Implications.
Doghri R; Houcine Y; Boujelbène N; Driss M; Charfi L; Abbes I; Mrad K; Sellami R
Appl Immunohistochem Mol Morphol; 2019 Oct; 27(9):678-682. PubMed ID: 31567138
[TBL] [Abstract][Full Text] [Related]
7. Mismatch repair deficiency identifies patients with high-intermediate-risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: A prognostic biomarker.
Backes FJ; Haag J; Cosgrove CM; Suarez A; Cohn DE; Goodfellow PJ
Cancer; 2019 Feb; 125(3):398-405. PubMed ID: 30561762
[TBL] [Abstract][Full Text] [Related]
8. Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D.
Timmerman S; Van Rompuy AS; Van Gorp T; Vanden Bempt I; Brems H; Van Nieuwenhuysen E; Han SN; Neven P; Victoor J; Laenen A; Vergote I
Gynecol Oncol; 2020 Apr; 157(1):245-251. PubMed ID: 31980219
[TBL] [Abstract][Full Text] [Related]
9. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA
Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
[TBL] [Abstract][Full Text] [Related]
10. [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
Jin W; Wang LQ; Liu Y; Liu AJ
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):823-830. PubMed ID: 30585020
[No Abstract] [Full Text] [Related]
11. Discordant loss of mismatch repair proteins in advanced endometrial endometrioid carcinoma compared to paired primary uterine tumors.
Ta RM; Hecht JL; Lin DI
Gynecol Oncol; 2018 Dec; 151(3):401-406. PubMed ID: 30340772
[TBL] [Abstract][Full Text] [Related]
12. Women 50 years or younger with endometrial cancer: the argument for universal mismatch repair screening and potential for targeted therapeutics.
Ring KL; Connor EV; Atkins KA; Ricketts W; Kashlan B; Modesitt SC
Int J Gynecol Cancer; 2013 Jun; 23(5):853-60. PubMed ID: 23552806
[TBL] [Abstract][Full Text] [Related]
13. [Not Available].
Joly F; Querleu D; Namer M; Pujade-Lauraine E
Bull Cancer; 2017 May; 104 Suppl 1():S1-S5. PubMed ID: 28625310
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA
Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767
[TBL] [Abstract][Full Text] [Related]
15. Advances in the management of recurrent endometrial cancer.
Bradford LS; Rauh-Hain JA; Schorge J; Birrer MJ; Dizon DS
Am J Clin Oncol; 2015 Apr; 38(2):206-12. PubMed ID: 23764681
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic implications of DNA mismatch repair status in endometrial carcinomas.
Shikama A; Minaguchi T; Matsumoto K; Akiyama-Abe A; Nakamura Y; Michikami H; Nakao S; Sakurai M; Ochi H; Onuki M; Satoh T; Oki A; Yoshikawa H
Gynecol Oncol; 2016 Feb; 140(2):226-33. PubMed ID: 26644264
[TBL] [Abstract][Full Text] [Related]
18. Interobserver Agreement for Mismatch Repair Protein Immunohistochemistry in Endometrial and Nonserous, Nonmucinous Ovarian Carcinomas.
Sari A; Pollett A; Eiriksson LR; Lumsden-Johanson B; Van de Laar E; Kazerouni H; Salehi A; Sur M; Lytwyn A; Ferguson SE
Am J Surg Pathol; 2019 May; 43(5):591-600. PubMed ID: 30864976
[TBL] [Abstract][Full Text] [Related]
19. Surveillance procedures for patients treated for endometrial cancer: a review of the literature.
Sartori E; Pasinetti B; Chiudinelli F; Gadducci A; Landoni F; Maggino T; Piovano E; Zola P
Int J Gynecol Cancer; 2010 Aug; 20(6):985-92. PubMed ID: 20683406
[TBL] [Abstract][Full Text] [Related]
20. Recommandations francophones pour la pratique clinique concernant la prise en charge des cancers du sein de Saint-Paul-de-Vence 2022-2023.
Gligorov J; Benderra MA; Barthere X; de Forceville L; Antoine EC; Cottu PH; Delaloge S; Pierga JY; Belkacemi Y; Houvenaegel G; Pujol P; Rivera S; Spielmann M; Penault-Llorca F; Namer M;
Bull Cancer; 2023 Nov; 110(10S):10S1-10S43. PubMed ID: 38061827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
